Table 1

Clinical characteristics and plasma CCL3 and CCL4 concentrations in EBV-negative immunocompromised patients

Patient no.Age (yr)/genderaDiagnosisConcn (pg/ml)
CCL3CCL4
15/MHemophagocytotic syndrome5.021.8
215/MBone marrow transplantation5.039.3
33/FLiver transplantation10.019.3
44/FLiver transplantation5.035.3
59/FLiver transplantation0.074.4
64/FLiver transplantation0.0175.9
711/FLiver transplantation0.033.7
88/MBone marrow transplantation0.0168.0
94/MLiver transplantation33.3202.5
104/FLiver transplantation11.6147.5
1113/FBone marrow transplantation8.373.8
128/MBone marrow transplantation6.6141.3
1311/FLiver transplantation1.615.0
146/FLiver transplantation0.013.8
154/FBone marrow transplantation8.396.9
169/FLiver transplantation5.036.9
177/MLiver transplantation23.387.5
181/FLiver transplantation41.1154.4
Avg9.185.4
  • a M, male; F, female.